# OneBlood, Inc. – FDA Inspection, Mar 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/3cdf69a6-2397-4741-b927-490fba121d93
Source feed: FDA_Inspections

> FDA inspection 1204182 of OneBlood, Inc., March 23, 2023. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1204182
- Company Name: OneBlood, Inc.
- Inspection Date: 2023-03-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1303580 - 2026-01-23](https://www.keypedia.com/records/fda_inspections/oneblood-inc/db47f252-3776-46e4-a3cd-a7f9ebcab5be)
- [FDA Inspection 1086790 - 2019-04-18](https://www.keypedia.com/records/fda_inspections/oneblood-inc/c74d55de-e464-4845-941a-b76cf7035d6d)
- FDA Inspection 1012284 - 2017-02-03
- FDA Inspection 932398 - 2015-06-23
- FDA Inspection 811064 - 2012-12-12

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/charles-d-boison/b128f4a3-c1b1-409f-9291-27deb111d1e5)

Company: https://www.keypedia.com/companies/oneblood-inc/ed0d4d35-e4b5-4e36-b8c5-a071e0e34864

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d